skip to Main Content
Technology
Partnering
News
Team
Resources
Contact Us
News & Articles
All
News
Press Releases
Avectas Opens new Labs in Cherrywood
The Advanced Therapies Week 2024 Miami, featured our own Dr. Lisa O’Flynn as a guest speaker at the Non-Viral Solutions for Gene Therapy Session.
Avectas announces the appointment of Dr. Ann Brady as Chief Business Officer
Avectas Launches the Solupore® Platform for the Clinical Manufacturing of Next- Generation Gene-Modified Cell Therapies with Unparalleled Cell Health and Functionality
Avectas, CCRM and OmniaBio Expand their Collaboration to Accelerate the Manufacture of Edited iPSCs Using SOLUPORE® Technology
Search articles
Top articles
Dr. Jamie Frankish presented at ISCT Vancouver 2024. “Novel non-viral delivery technology, Solupore®, enables gene delivery for a healthier, more potent, and significantly more effective CAR-T therapy in vivo.”
May 15, 2024
The Advanced Therapies Week 2024 Miami, featured our own Dr. Lisa O’Flynn as a guest speaker at the Non-Viral Solutions for Gene Therapy Session.
January 9, 2024
Avectas announces the appointment of Dr. Ann Brady as Chief Business Officer
February 1, 2023
Popular articles
×
